Atara Biotherapeutics (ATRA) EPS (Basic) Growth (1y) (2014 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 39.88% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn | -102.31% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 515.34% |
| 10 | Atara Biotherapeutics | 146.20 Mn | 129.64 Mn | 439,000.00 | -264.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -264.31% |
| Mar 31, 2026 | -108.34% |
| Dec 31, 2025 | 51.90% |
| Sep 30, 2025 | 89.19% |
| Jun 30, 2025 | 106.31% |
| Mar 31, 2025 | 162.54% |
| Dec 31, 2024 | 88.17% |
| Sep 30, 2024 | 82.11% |
| Jun 30, 2024 | 81.67% |
| Mar 31, 2024 | 68.60% |
| Dec 31, 2023 | 21.73% |
| Sep 30, 2023 | 20.10% |
| Jun 30, 2023 | -472.29% |
| Mar 31, 2023 | 17.78% |
| Dec 31, 2022 | 26.69% |
| Sep 30, 2022 | 9.23% |
| Jun 30, 2022 | 119.99% |
| Mar 31, 2022 | -2.12% |
| Dec 31, 2021 | 9.30% |
| Sep 30, 2021 | 1.24% |